• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2014 Fiscal Year Final Research Report

Role of drug metabolizing enzymes in acquired resistance of breast cancer cells to anticancer drugs

Research Project

  • PDF
Project/Area Number 24590217
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Medical pharmacy
Research InstitutionTokyo University of Pharmacy and Life Science

Principal Investigator

OGURA Kenichiro  東京薬科大学, 薬学部, 准教授 (10185564)

Project Period (FY) 2012-04-01 – 2015-03-31
Keywords薬物代謝酵素 / 乳癌 / 耐性化 / グルクロン酸抱合 / タモキシフェン / MCF-7
Outline of Final Research Achievements

In this study, to clarify the generation mechanism of breast cancer cells resistant to anti-breast cancer drug tamoxifen (TAM), and was intended to be the beginning of the resistance overcome. When a drug-metabolizing enzyme UGT1A4 that inactivates TAM in breast cancer cells was overexpressed, it was revealed that the intracellular concentrations of TAM is reduced by excretion as an inactive form via transporter MRP-1. Furthermore, unlike mechanism TAM resistance of the that have been reported so far in TAM resistant strain, that overexpression of the drug-metabolizing enzyme can be one of TAM resistance mechanism of breast cancer was suggested.

Free Research Field

薬物代謝・毒性学

URL: 

Published: 2016-06-03  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi